Dr. Stephen J. Kolb MD, PHD
Neurologist | Neurology
1654 Upham Dr 445 Means Hall Columbus OH, 43210About
I approach patient care the way I would expect my physician to approach me - with competence, honesty and a collaborative style. I am a physician/scientist. I care for patients who suffer from Lou G ... ...
Board Certification
Psychiatry and NeurologyAmerican Board of Psychiatry and NeurologyABPN
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Light scattering and transmission electron microscopy studies reveal a mechanism for calcium/calmodulin-dependent protein kinase II self-association.
- The survival of motor neurons protein determines the capacity for snRNP assembly: biochemical deficiency in spinal muscular atrophy.
- Channel permeant cations compete selectively with noncompetitive inhibitors of the nicotinic acetylcholine receptor.
- Molecular functions of the SMN complex.
- RNA processing defects associated with diseases of the motor neuron.
- Spliceosomal small nuclear ribonucleoprotein biogenesis defects and motor neuron selectivity in spinal muscular atrophy.
- Mutant HSPB1 overexpression in neurons is sufficient to cause age-related motor neuronopathy in mice.
- Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS.
- Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial.
- NeuroNEXT SMA biomarkers study.
- A large animal model of spinal muscular atrophy and correction of phenotype.
- Electrophysiological Motor Unit Number Estimation (MUNE) Measuring Compound Muscle Action Potential (CMAP) in Mouse Hindlimb Muscles.
- Genetic testing and genetic counseling for amyotrophic lateral sclerosis: an update for clinicians.
- Spinal Muscular Atrophy Biomarker Measurements from Blood Samples in a Clinical Trial of Valproic Acid in Ambulatory Adults.
- Variable phenotypic expression and onset in MYH14 distal hereditary motor neuropathy phenotype in a large, multigenerational North American family.
Clinical Trials
Fellowships
- Research: University of Pennsylvania Hospital 2002
Dr. Stephen J. Kolb MD, PHD's Practice location
Dr. Stephen J. Kolb MD, PHD's reviews
Write ReviewPatient Experience with Dr. Kolb
Recommended Articles
- One Step Closer to a Cure: New Developments in Parkinson’s Research
Parkinson's disease is a neurodegenerative disease that affects a lot of people worldwide with an estimated figure of about 1 million in the United States alone, according to the National Parkinson’s Foundation. Despite the sheer amount of support available for patients as seen in the dozens of...
- Dealing with Multiple Sclerosis Fatigue
Multiple sclerosis is a poorly understood autoimmune disease with a variety of symptoms, not all of which are felt by every person. Perhaps the most common symptom of MS is fatigue, and even that does not affect everyone equally.Tiredness and lassitudeFatigue can manifest itself either mentally or...
- Alzheimer 's Disease: Understand the Diagnosis
What is Alzheimer’s disease?Alzheimer’s disease is characterized by the gradual death of the brain cells, which affects the transmission of signals. This in turn, impairs memory, judgment, and cognitive abilities of the patient, and they find it difficult to carry out the day-to-day activities...
- Is It Possible Extra-Virgin Olive Oil Can Help Preserve Memories?
An increasing number of research studies are turning their attention to the way that diet affects the brain. Studies on gut flora have linked depression and anxiety to the complex system of microorganisms that live in the gastrointestinal tract. Certain fruits and food groups have been found to...
- Dodgers’ Closer Kenley Jansen Helps Pay for Multiple Sclerosis Medical Treatment for Teenager
Closer for the Dodgers, Kenley Jansen, was the savior for several of the team’s games. Now, Jansen has jumped at the opportunity to help a man in dire need of medical treatment that he cannot afford. ...
- Recently Approved Multiple Sclerosis Drug Shows Promise
Only 50 years ago, there was no way possible to treat multiple sclerosis. Then, in the mid-1970s, a team of researchers and doctors used chemotherapy for the first time to treat the neurological disease. Since that first treatment, more than 10 new drugs have been developed and approved. Some of...
Nearby Providers
- Dr. Maria Kataki MD456 W 10th Ave Columbus OH 43210
- Dr. Ekokobe Fonkem D.O1654 Upham Dr Columbus OH 43210
- Dr. Rawan Tarawneh MD410 W 10th Ave Columbus OH 43210
- Dr. Meena S Khan M.D.473 W 12th Ave Columbus OH 43210
- Dr. Miriam L Freimer MD456 W 10th Ave Columbus OH 43210
- Dr. Douglas W. Scharre MD1581 Dodd Dr Columbus OH 43210